|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
36.600 -0.250 (-0.678%) | 2020/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2019/06 RMB(K¥) | 2018/06 RMB(K¥) | 2017/06 RMB(K¥) | 2016/06 RMB(K¥) | ||
| Turnover | 13,965,179 | -0.852% | 14,085,146 | 11,766,540 | 8,276,941 | 6,877,865 | |
| Cost of Sales | (6,215,872) | 11.018% | (5,598,983) | (4,945,865) | (3,571,893) | (3,228,575) | |
| Gross Profit | 7,749,307 | -8.683% | 8,486,163 | 6,820,675 | 4,705,048 | 3,649,290 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (42,765) | 95.114% | (21,918) | (9,094) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 652,406 | -11.131% | 734,122 | 707,759 | 754,379 | 717,196 | |
| Profit / (Loss) before Taxation | 2,301,688 | 4.806% | 2,196,150 | 2,037,697 | 2,179,164 | 1,929,770 | |
| Taxation | (392,081) | 4.133% | (376,521) | (299,745) | (252,545) | (181,145) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (194,897) | -35.785% | (303,509) | (177,481) | (237,559) | (248,359) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,714,710 | 13.099% | 1,516,120 | 1,560,471 | 1,689,060 | 1,500,266 | |
| Net Finance Costs / (Income) | 331,442 | -27.993% | 460,290 | 381,396 | 234,052 | 198,480 | |
| Depreciation & Amortisation | 836,268 | 12.971% | 740,252 | 601,110 | 414,381 | 378,667 | |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A | |
Market Valuation Indicators
| EPS (cts) | 67.000 | -- | 59.000 | 63.000 | 70.000 | 65.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 0.000% | 0.000% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 12.869 | -- | 11.187 | 10.223 | 9.861 | 8.183 |
| Remarks: | Real time quote last updated: 26/02/2021 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,714,710 |
| %Change | 13.099% |
| EPS / (LPS) | RMB 0.670 |
| NBV Per Share (¥) | RMB 12.869 |